Skip to main
MDT

Medtronic (MDT) Stock Forecast & Price Target

Medtronic (MDT) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 17%
Buy 44%
Hold 39%
Sell 0%
Strong Sell 0%

Bulls say

Medtronic is positioned for growth in the coming years, with its strong portfolio of therapeutic medical devices and expanding international presence. The recent acquisition of Scientia Vascular will likely drive faster growth in the neurovascular market, and the company is in the early stages of a strong product cycle. While there are potential risks such as market share loss and disappointing sales, Medtronic's strong financial performance and ongoing product innovation make it an attractive investment opportunity.

Bears say

Medtronic is actively pursuing growth through acquisitions, recently announcing a $550M cash acquisition of Scientia Vascular, which they expect to be accretive in FY27. However, the company's recent operating margin decline and inconsistent execution may hinder its ability to achieve high-single digit EPS growth and P/E multiple expansion.

Medtronic (MDT) has been analyzed by 18 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 44% recommend Buy, 39% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medtronic (MDT) Forecast

Analysts have given Medtronic (MDT) a Buy based on their latest research and market trends.

According to 18 analysts, Medtronic (MDT) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $108.56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $108.56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medtronic (MDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.